Organon & Co | Driftsresultat



Operating Profit Lave om Dato
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Celltrion KRW 207.69B 135.2B 2024-09
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Dianthus Therapeutics USD -29900000 7.7M 2024-09
Ecofibre AUD -4680000 38.98M 2024-06
Gilead Sciences USD 2.45B 1.56B 2024-12
Glaxosmithkline GBP 702M 513M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 37.16M 17.88M 2024-06
Malin Corporation EUR -700000 1.6M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Merck USD 4.3B 369M 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Novartis USD 3.4B 193M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Organon & Co USD 129M 78M 2024-12
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 144.16M 14.73M 2024-12
Sartorius EUR 68.2M 38.1M 2024-09
Sino Biopharmaceutical CNY 1.73B 948.23M 2024-06
Tilray USD -42218000 5.65M 2024-11



Organon & Co Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.